Trending

MultiMetaVerse Plans to Acquire Equity Stake in Taomee June 2, 2023

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody June 2, 2023

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO June 2, 2023

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data June 2, 2023

Monopar Reports Positive Camsirubicin Phase 1b Trial Update June 1, 2023

Next

Prev

$400.47 $2.66 0.66%

$180.95 $0.86 0.48%

$124.25 $1.48 1.21%

$213.97 $6.45 3.11%

$125.23 $0.86 0.69%

Symbol: NASDAQ:ACIU

24/7 Market News- Biotech Headlines

DENVER, Colo., July 16, 2020- Today’s biotech headlines include developments from Emmaus Life Sciences, Inc. (OTCQB:EMMA), AC Immune SA (NASDAQ:ACIU), ...